Astrazeneca Pharma India
May 29, 2012 at 15:09 | Source: PTI
May 29, 2012 at 08:28 | Source: CNBC-TV18
May 28, 2012 at 11:04 | Source: Moneycontrol.com
May 25, 2012 at 08:19 | Source: Moneycontrol.com
May 21, 2012 at 08:14 | Source: CNBC-TV18
May 19, 2012 at 16:17 | Source: Moneycontrol.com
News across the web »
May 18, 2012 at 22:51 | Source: FirstPost
May 13, 2012 at 06:37 | Source: The Hindu BusinessLine
May 12, 2012 at 18:00 | Source: NDTV Profit
May 12, 2012 at 14:21 | Source: The Hindu BusinessLine
May 11, 2012 at 11:26 | Source: Economic Times
Interact & exchange stock tips & market info »
Related News »
The Board of Directors of AstraZeneca Pharma India Ltd at its meeting held on May 11, 2012, has recommended a Dividend of Rs. 3.50/- per Equity Share of face value of Rs. 2/- each (175%) for the Financial Year ended March 31, 2012, subject to the approval ...
May 13, 2012 at 15:35 | Source: equitybulls.com
AstraZeneca Pharma India has tanked 7% to Rs 1,655 after reporting a net loss of Rs 33 crore during the fourth quarter ended March 31, due to a voluntary recall of sterile products and higher employee cost. The pharmaceutical company had a net profit of Rs ...
May 14, 2012 at 06:30 | Source: Business Standard
AstraZeneca Pharma India Ltd has announced the financial results for the quarter & year ended March 31, 2012. The Company has posted a net loss of Rs. (330.045) million for the quarter ended March 31, 2012 where as the same was at net profit of Rs.
May 13, 2012 at 15:35 | Source: equitybulls.com
AstraZeneca Pharma India spurted 20% on huge volumes. According to market buzz, UK-based AstraZeneca is planning to delist the Indian unit. Dish TV India rallied over 10% to Rs 61 on reporting a healthy 60% year-on-year (y-o-y) growth in standalone ...
May 17, 2012 at 10:44 | Source: Business Standard
Its lung cancer drug Gestinib, which is sold under brand name Iressa by AstraZeneca will cost ... the analyst says. Swiss pharma major Roche had earlier this year signed a manufacturing deal with India's Emcure Pharma so that its anti-cancer ...
May 16, 2012 at 10:23 | Source: MoneyControl.com
selling it mostly to big pharma or medical manufacturing groups. Of more interest, however, is just how this fits into Piramal’s overall plans to become India’s first true developer of global pharmaceuticals products, a mark he has pledged ...
May 16, 2012 at 16:50 | Source: Financial Times
Stocks like Fairfield Atlas are up about 104.15 per cent, Thomas Cook 85 per cent, BOC India 61.26 per cent, Fresenius Kabi Oncology 62.1 per cent, AstraZeneca Pharma 55.72 per cent, Singer India 53 per cent, Honeywell Automation India 49.12 per cent ...
May 8, 2012 at 05:18 | Source: moneyguruindia.com
AstraZeneca Pharma India spurted 20% on huge volumes. Dish TV India [ Get Quote] rallied over 10% to Rs 61 on reporting a healthy 60% year-on-year (y-o-y) growth in standalone operating profit at Rs 144 crore for the fourth quarter ended March.
May 17, 2012 at 10:51 | Source: rediff.com
I think there are about 13 candidates, especially from the MNC point of view, say Astrazeneca Pharma, 3M India, Honeywell Automation, Fresenius Kabi. But in most cases, the retail holding is a big challenge.
May 24, 2012 at 07:36 | Source: MoneyControl.com
ABUJA— Pharmaceutical companies in India has reduced the cost ... Gestinib (sold under brand name Iressa by AstraZeneca for Rs 10,000/-) will cost Rs 4,250/-, while prices of is Temozolamide (sold by German pharma company Schering), used to treat brain ...
May 20, 2012 at 23:05 | Source: Vanguard